Raymond James Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.78M | Sell |
3,829
-232
| -6% | -$108K | 0.04% | 348 |
|
|
2024
Q2 | $1.9M | Sell |
4,061
-142
| -3% | -$66.6K | 0.04% | 324 |
|
|
2024
Q1 | $1.76M | Buy |
4,203
+101
| +2% | +$42.2K | 0.04% | 339 |
|
|
2023
Q4 | $1.67M | Sell |
4,102
-107
| -3% | -$43.5K | 0.04% | 337 |
|
|
2023
Q3 | $1.46M | Buy |
4,209
+25
| +0.6% | +$8.69K | 0.04% | 331 |
|
|
2023
Q2 | $1.47M | Sell |
4,184
-131
| -3% | -$46.1K | 0.04% | 331 |
|
|
2023
Q1 | $1.36M | Sell |
4,315
-58
| -1% | -$18.3K | 0.04% | 343 |
|
|
2022
Q4 | $1.26M | Sell |
4,373
-55
| -1% | -$15.9K | 0.04% | 347 |
|
|
2022
Q3 | $1.28M | Sell |
4,428
-661
| -13% | -$191K | 0.05% | 319 |
|
|
2022
Q2 | $1.43M | Sell |
5,089
-1,143
| -18% | -$322K | 0.05% | 303 |
|
|
2022
Q1 | $1.63M | Buy |
6,232
+401
| +7% | +$105K | 0.05% | 301 |
|
|
2021
Q4 | $1.28M | Sell |
5,831
-362
| -6% | -$79.5K | 0.04% | 363 |
|
|
2021
Q3 | $1.12M | Buy |
6,193
+1,133
| +22% | +$206K | 0.04% | 372 |
|
|
2021
Q2 | $1.02M | Sell |
5,060
-220
| -4% | -$44.3K | 0.03% | 398 |
|
|
2021
Q1 | $1.13M | Buy |
5,280
+486
| +10% | +$104K | 0.04% | 337 |
|
|
2020
Q4 | $1.13M | Buy |
4,794
+348
| +8% | +$82.2K | 0.04% | 326 |
|
|
2020
Q3 | $1.21M | Buy |
4,446
+483
| +12% | +$131K | 0.05% | 276 |
|
|
2020
Q2 | $1.15M | Buy |
3,963
+415
| +12% | +$121K | 0.06% | 275 |
|
|
2020
Q1 | $844K | Sell |
3,548
-497
| -12% | -$118K | 0.05% | 299 |
|
|
2019
Q4 | $886K | Sell |
4,045
-861
| -18% | -$189K | 0.04% | 331 |
|
|
2019
Q3 | $831K | Buy |
4,906
+536
| +12% | +$90.8K | 0.04% | 340 |
|
|
2019
Q2 | $802K | Sell |
4,370
-17
| -0.4% | -$3.12K | 0.04% | 329 |
|
|
2019
Q1 | $807K | Sell |
4,387
-452
| -9% | -$83.1K | 0.05% | 325 |
|
|
2018
Q4 | $802K | Buy |
4,839
+299
| +7% | +$49.6K | 0.05% | 293 |
|
|
2018
Q3 | $875K | Buy |
4,540
+65
| +1% | +$12.5K | 0.05% | 302 |
|
|
2018
Q2 | $761K | Buy |
4,475
+174
| +4% | +$29.6K | 0.05% | 323 |
|
|
2018
Q1 | $701K | Buy |
4,301
+342
| +9% | +$55.7K | 0.05% | 307 |
|
|
2017
Q4 | $594K | Buy |
3,959
+49
| +1% | +$7.35K | 0.04% | 339 |
|
|
2017
Q3 | $594K | Buy |
3,910
+91
| +2% | +$13.8K | 0.04% | 331 |
|
|
2017
Q2 | $492K | Buy |
3,819
+154
| +4% | +$19.8K | 0.04% | 377 |
|
|
2017
Q1 | $401K | Sell |
3,665
-20
| -0.5% | -$2.19K | 0.03% | 419 |
|
|
2016
Q4 | $272K | Sell |
3,685
-45
| -1% | -$3.32K | 0.02% | 514 |
|
|
2016
Q3 | $325K | Buy |
3,730
+143
| +4% | +$12.5K | 0.03% | 442 |
|
|
2016
Q2 | $308K | Sell |
3,587
-321
| -8% | -$27.6K | 0.03% | 458 |
|
|
2016
Q1 | $311K | Sell |
3,908
-1,589
| -29% | -$126K | 0.03% | 446 |
|
|
2015
Q4 | $692K | Buy |
5,497
+1,667
| +44% | +$210K | 0.06% | 276 |
|
|
2015
Q3 | $399K | Sell |
3,830
-205
| -5% | -$21.4K | 0.04% | 348 |
|
|
2015
Q2 | $498K | Buy |
4,035
+20
| +0.5% | +$2.47K | 0.05% | 316 |
|
|
2015
Q1 | $473K | Sell |
4,015
-619
| -13% | -$72.9K | 0.05% | 335 |
|
|
2014
Q4 | $551K | Buy |
4,634
+317
| +7% | +$37.7K | 0.06% | 301 |
|
|
2014
Q3 | $485K | Buy |
4,317
+382
| +10% | +$42.9K | 0.06% | 309 |
|
|
2014
Q2 | $372K | Buy |
3,935
+98
| +3% | +$9.27K | 0.04% | 375 |
|
|
2014
Q1 | $271K | Buy |
3,837
+679
| +22% | +$48K | 0.03% | 438 |
|
|
2013
Q4 | $234K | Buy |
3,158
+289
| +10% | +$21.4K | 0.03% | 476 |
|
|
2013
Q3 | $217K | Sell |
2,869
-298
| -9% | -$22.5K | 0.03% | 479 |
|
|
2013
Q2 | $253K | Buy |
+3,167
| New | +$253K | 0.04% | 381 |
|